• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑郁症和精神分裂症患者脑脊液中促肾上腺皮质激素释放因子样免疫反应性

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia.

作者信息

Banki C M, Bissette G, Arato M, O'Connor L, Nemeroff C B

出版信息

Am J Psychiatry. 1987 Jul;144(7):873-7. doi: 10.1176/ajp.144.7.873.

DOI:10.1176/ajp.144.7.873
PMID:3496802
Abstract

To further investigate the hypothesis that hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with depression may be mediated by hypersecretion of corticotropin-releasing factor (CRF), the authors measured CRF-like immunoreactivity in CSF samples from 138 neurological control, 54 depressed, and 27 nondepressed (23 schizophrenic and four manic) subjects. The CSF CRF concentration was markedly higher (almost twofold) in depressed patients than in control subjects and nondepressed psychiatric patients. The concentration of CSF CRF was slightly but significantly higher in schizophrenic patients than in control subjects. These findings provide further support for the hypothesis that CRF hypersecretion occurs in major depression.

摘要

为了进一步研究抑郁症患者下丘脑 - 垂体 - 肾上腺轴功能亢进可能由促肾上腺皮质激素释放因子(CRF)分泌过多介导这一假说,作者测量了138名神经科对照者、54名抑郁症患者以及27名非抑郁症患者(23名精神分裂症患者和4名躁狂症患者)脑脊液样本中CRF样免疫反应性。抑郁症患者脑脊液中的CRF浓度显著高于(几乎是两倍)对照者和非抑郁症精神科患者。精神分裂症患者脑脊液中CRF的浓度比对照者略高,但有显著差异。这些发现为CRF分泌过多发生在重度抑郁症中的假说提供了进一步的支持。

相似文献

1
CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia.抑郁症和精神分裂症患者脑脊液中促肾上腺皮质激素释放因子样免疫反应性
Am J Psychiatry. 1987 Jul;144(7):873-7. doi: 10.1176/ajp.144.7.873.
2
Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients.抑郁症患者脑脊液中促肾上腺皮质激素释放因子样免疫反应性浓度升高。
Science. 1984 Dec 14;226(4680):1342-4. doi: 10.1126/science.6334362.
3
CSF corticotropin-releasing hormone in depressed patients and normal control subjects.抑郁症患者和正常对照受试者脑脊液中的促肾上腺皮质激素释放激素
Am J Psychiatry. 1987 May;144(5):641-5. doi: 10.1176/ajp.144.5.641.
4
Limbic-hypothalamic-pituitary-adrenal axis activity and ventricular-to-brain ratio studies in affective illness and schizophrenia.
Neuropsychopharmacology. 1992 Feb;6(2):95-100.
5
CSF somatostatin and abnormal response to dexamethasone administration in schizophrenic and depressed patients.精神分裂症和抑郁症患者脑脊液中生长抑素及对地塞米松给药的异常反应。
Arch Gen Psychiatry. 1986 Apr;43(4):365-9. doi: 10.1001/archpsyc.1986.01800040075011.
6
Corticotropin-releasing factor test in melancholic patients in depressed state versus recovery: a comparative study.抑郁状态与康复期忧郁症患者的促肾上腺皮质激素释放因子试验:一项对比研究。
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1027-33. doi: 10.1016/j.pnpbp.2007.03.002. Epub 2007 Mar 7.
7
Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression.
Am J Psychiatry. 1993 Apr;150(4):656-7. doi: 10.1176/ajp.150.4.656.
8
Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans.健康人和抑郁症患者脑脊液中促肾上腺皮质激素释放激素的系列浓度
J Clin Endocrinol Metab. 1992 Jun;74(6):1325-30. doi: 10.1210/jcem.74.6.1317385.
9
CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures.阿尔茨海默病和重度抑郁症患者脑脊液中的生长抑素:与下丘脑 - 垂体 - 肾上腺轴及临床指标的关系
Psychoneuroendocrinology. 1993;18(7):509-19. doi: 10.1016/0306-4530(93)90044-l.
10
Diazepam-binding inhibitor and corticotropin-releasing hormone in cerebrospinal fluid.
Acta Psychiatr Scand. 1989 Sep;80(3):287-91. doi: 10.1111/j.1600-0447.1989.tb01339.x.

引用本文的文献

1
The cortisol axis and psychiatric disorders: an updated review.皮质醇轴与精神障碍:最新综述
Pharmacol Rep. 2025 Sep 16. doi: 10.1007/s43440-025-00782-x.
2
Structure-based drug discovery of a corticotropin-releasing hormone receptor 1 antagonist using an X-ray free-electron laser.基于结构的促肾上腺皮质激素释放激素受体 1 拮抗剂的药物研发:使用 X 射线自由电子激光。
Exp Mol Med. 2023 Sep;55(9):2039-2050. doi: 10.1038/s12276-023-01082-1. Epub 2023 Sep 1.
3
By what molecular mechanisms do social determinants impact cardiometabolic risk?
社会决定因素通过哪些分子机制影响心血管代谢风险?
Clin Sci (Lond). 2023 Mar 31;137(6):469-494. doi: 10.1042/CS20220304.
4
[Latest Findings on the Interaction Mechanism Between Depressive Disorder and Intestinal Permeability].[抑郁症与肠道通透性相互作用机制的最新研究发现]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Mar;54(2):257-262. doi: 10.12182/20230360503.
5
Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies.烧毁房屋:重塑精神病学药物研发以开发靶向疗法。
Mol Psychiatry. 2023 Jan;28(1):68-75. doi: 10.1038/s41380-022-01887-y. Epub 2022 Dec 2.
6
Mental health and periodontal and peri-implant diseases.心理健康与牙周病和种植体周围病。
Periodontol 2000. 2022 Oct;90(1):106-124. doi: 10.1111/prd.12452. Epub 2022 Aug 1.
7
Mental depression: Relation to different disease status, newer treatments and its association with COVID-19 pandemic (Review).精神抑郁:与不同疾病状况、新治疗方法的关系及其与 COVID-19 大流行的关联(综述)。
Mol Med Rep. 2021 Dec;24(6). doi: 10.3892/mmr.2021.12479. Epub 2021 Oct 11.
8
PSD-93 up-regulates the synaptic activity of corticotropin-releasing hormone neurons in the paraventricular nucleus in depression.PSD-93 上调抑郁状态下室旁核促肾上腺皮质激素释放激素神经元的突触活动。
Acta Neuropathol. 2021 Dec;142(6):1045-1064. doi: 10.1007/s00401-021-02371-7. Epub 2021 Sep 18.
9
Chronic distress and the vulnerable host: a new target for HIV treatment and prevention?慢性应激与易感宿主:HIV治疗与预防的新靶点?
Neurobehav HIV Med. 2016;7:53-75. doi: 10.2147/nbhiv.s86309. Epub 2016 Dec 28.
10
Mathematical modeling of depressive disorders: Circadian driving, bistability and dynamical transitions.抑郁症的数学建模:昼夜节律驱动、双稳态和动态转变。
Comput Struct Biotechnol J. 2020 Nov 21;19:664-690. doi: 10.1016/j.csbj.2020.10.035. eCollection 2021.